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Abstract
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Serotonin 5-HT2A receptors are expressed throughout the mesolimbic and mesocortical dopamine
pathways, and manipulation of this receptor system has a profound impact on dopamine functions
and dopamine-mediated behaviors. It is highly likely that 5-HT2A receptors may also modulate the
D2-mediated maternal effects. The present study investigated this issue and also explored the
possible behavioral mechanisms. We tested the effects of two D2 drugs (an agonist quinpirole: 0.5,
1.0 mg/kg, and a potent D2 antagonist haloperidol: 0.05, 0.10 mg/kg, sc) and their combinations
with two 5-HT2A drugs (a selective 5-HT2A agonist TCB-2: 2.5 mg/kg, and 5-HT2A antagonist
MDL100907, 1.0 mg/kg, sc) on maternal behavior in Sprague-Dawley postpartum females.
Individually, TCB-2 (2.5 mg/kg, sc) and quinpirole (0.5 and 1.0 mg/kg, sc) reduced pup preference
and disrupted home-cage maternal behavior. In contrast, haloperidol (0.10 mg/kg, sc) only
disrupted home-cage maternal behavior, but did not suppress pup preference. MDL100907 (1.0
mg/kg, sc) by itself had no effect on either pup preference or maternal behavior. When
administered in combination, pretreatment of TCB-2 did not alter quinpirole’s disruption of pup
preference and home-cage maternal behavior (possibly due to the floor effect), however, it did
enhance haloperidol’s disruption of pup retrieval in the home cage. MDL100907 had no effect
both quinpirole’s and haloperidol’s disruption of pup preference and home-cage maternal
behavior. Interestingly, haloperidol attenuated TCB-2’s disruptive effect on pup preference. These
findings suggest that activation of 5-HT2A receptors tends to enhance D2-mediated maternal
disruption, whereas blockade of 5-HT2A receptors is less effective. They also suggest that 5-HT2A
receptors may have a direct effect on maternal behavior independent of their interaction with D2
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receptors. The possible behavioral and neural mechanisms by which 5-HT2A-and D2-mediated
maternal effects and their interaction are discussed.

Keywords
Serotonin 2A receptor; Dopamine D2 receptor; Incentive motivation; Emotional processing; Pup
preference; Maternal behavior

1.

Introduction
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Maternal behavior in rats involves dramatic changes in the perceptional, emotional and
motivational responses of female rats toward infant rats (Numan and Young, 2016). Through
mother-infant interaction, the enduring mother–infant bond (maternal bond) is formed,
which drives a mother rat to display a strong preference to pups and pup-related cues over
other stimuli. This maternal attraction towards pups is mediated in part by the mesolimbic
and mesocortical dopamine pathways, the brain’s reward system (Numan, 2007). Functional
disturbances of these systems, such as lesions of nucleus accumbens (NAc), medial
prefrontal cortex (mPFC) or ventral tegmental area (VTA) (Afonso et al., 2007; Hansen,
1994; Hansen et al., 1991; Li and Fleming, 2003; Pereira and Morrell, 2011), or disruption
of connection between the medial preoptic area (MPOA) and VTA (Numan and Smith,
1984), or blockade of dopamine receptors in these regions (Keer and Stern, 1999; Numan et
al., 2005), reduces active maternal responses (e.g., pup retrieval and pup licking in the home
cage). Blockade of D1 and D2 receptors also prevents the development of pup-induced
conditioned place preference (Fleming et al., 1994). On the other hand, stimulation of the
dopamine systems by certain dopamine receptor agonists (e.g. apomorphine, quinpirole) is
also disruptive (Stern and Protomastro, 2000; Zhao and Li, 2010). Thus, it appears that a
balanced dopamine neurotransmission is critical for the normal expression of maternal
behavior. Based on the detailed behavioral analysis of dopamine-induced alterations in
maternal behavior, dopamine action on D2 receptors (possibly D1 too) exerts a regulatory
control over a mother rat’s (positively) emotional and motivation responses towards pups
(Numan and Young, 2016; Zhao and Li, 2009c).

Author Manuscript

Because stimulation and blockade of dopamine D2 receptor all cause a similar disruption of
maternal behavior, one critical question is whether they do so through the same or different
behavioral mechanisms. One idea is that stimulation or blockade of D2 receptors similarly
suppresses maternal motivation to achieve its maternal disruption, based on the observations
that blockade of D2 receptor specifically alters behavioral measures of maternal motivation
(Stern and Keer, 1999; Yang et al., 2015; Zhao and Li, 2009c). An alternative hypothesis is
that stimulation and blockade of D2 receptors act through different behavioral processes to
influence maternal behavior. For example, blockade of D2 receptors may disrupt maternal
behavior by suppressing maternal motivation; whereas stimulation of D2 receptors may do
so by certain aspects of executive functions (attention or working memory, behavioral
switching) necessary for the normal expression of maternal behavior. There is an ample
evidence in the literature that implicates D2 activation in the regulation of the above
mentioned behavioral functions, especially on the behavioral organization and emotion
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regulation (Agnoli et al., 2013; Herold, 2010; Liu et al., 2008; Pezze et al., 2007). To
identify the specific behavioral mechanisms underlying the D2-mediated maternal effects,
we have used various behavioral tests, such as the pup retrieval on the elevated plus maze
(Yang et al., 2015), pup separation (Zhao and Li, 2009c), and home cage maternal
observation (Zhao and Li, 2010).
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Besides dopamine, serotonin is recently shown to modulate maternal behavior via its action
on 5-HT2A receptors (and also 5-HT2C and 5-HT1A) (Chen et al., 2014; Gao et al., 2018b; Li
et al., 2018; Wu et al., 2016; Zhao and Li, 2010). We reported that activation of serotonin 5HT2A receptors disrupts maternal behavior in the home cage, whereas blockade of them has
little effect (Chen et al., 2014; Gao et al., 2018b; Zhao and Li, 2009a, 2010). Central
infusion of TCB-2 (a selective 5-HT2A agonist) into the medial prefrontal cortex (mPFC),
but not in the medial preoptic area (mPOA) also disrupts maternal behavior (Gao et al.,
2018b). Behaviorally, we showed that activation of 5-HT2A receptors does not seem to cause
a disruption of maternal motivation. Two pieces of evidence seem consistent with this
conclusion. The first one comes from the pup separation study (Gao et al., 2018b). Pup
separation is a powerful way to enhance maternal performance by increasing maternal
motivation (Hansen, 1994). Previous studies have shown that several hours of pup separation
(3–6 h) can completely restore the pup retrieval deficit induced by 6-OHDA lesions in the
ventral striatum (Hansen, 1994). The fact that pup separation fails to reduce TCB-2-induced
maternal disruption suggests that TCB-2 is not likely to severely impair maternal motivation.
If it does, TCB-2-treated dams should have performed better under the pup separation
condition than under the no-separation condition. The second piece of evidence comes from
a pup vs. male preference test (Wu et al., 2018). In this study, we found that TCB-2-treated
dams increased time spent with pups and decreased time with male. If TCB-2 suppress
maternal motivation, we should not expect to see an increase in pup exploration time. We
speculate that activation of 5-HT2A may disrupt some aspects of executive function by
diverting a mother rat’s focused attention on pups toward other environmental cues or by
increasing behavioral fragmentation and premature or ‘impulsive’ responding. This
hypothesis is consistent with extensive evidence showing the critical role of 5-HT2A
receptors in executive function and behavioral organization (Anastasio et al., 2015; Aznar
and Hervig Mel, 2016).
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Because 5-HT2A receptors are expressed throughout the mesolimbic and corticostriatal
circuits (Howell and Cunningham, 2015), and manipulation of this receptor system has a
profound impact on dopamine release and dopamine-mediated behaviors (Ichikawa et al.,
2001a; Ichikawa et al., 2001b; Ichikawa and Meltzer, 1995; Katsidoni et al., 2011; Kuroki et
al., 2003; Zayara et al., 2011), and there exists 5-HT2A-D2 heteromer and crosstalk (Albizu
et al., 2011), it is possible that 5-HT2A and D2 may interactively alter maternal responses via
various behavioral mechanisms. The primary goal of the present study was to investigate
how activation or blockade of 5-HT2A receptors alter the D2-mediated maternal effects and
identify the possible behavioral mechanisms. Toward this end, we tested a D2 agonist
quinpirole, and a D2 antagonist haloperidol, and their combination with a 5-HT2A agonist
TCB-2 and 5-HT2A antagonist MDL100907 in a pup preference test and a home-cage
maternal behavior test. The pup preference test mainly measures the emotional and attentive
processing of pups, as well as the sociability of mother rats. It is assumed that if a mother rat
Pharmacol Biochem Behav. Author manuscript; available in PMC 2020 May 01.
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possesses a strong positive emotion and focused attention towards her offspring, she will
spend more time in close proximity to the pups over other stimuli (Li et al., 2018; Wu et al.,
2018). Thus, this paradigm could be used to measure executive function of mother rats.
Following the pup preference test, we observed the home cage maternal behavior, focusing
on the active responses such as pup retrieval and pup licking. Based on the evidence that
blockade of 5-HT2A receptors is able to inhibit the mesolimbic dopamine function, while
activation of 5-HT2A receptors enhance it (Celada et al., 2013; Hamon and Blier, 2013;
Howell and Cunningham, 2015), we hypothesized that MDL100907 would reduce the
quinpirole-induced maternal disruption, but enhance the haloperidol-induced one.
Conversely, TCB-2 would enhance the quinpirole-induced maternal disruption, but reduce
the haloperidol-induced one.

2.
Author Manuscript

2.1.

Materials and methods
Animals

Author Manuscript

Virgin female Sprague-Dawley rats weighing 220–260 g were purchased from Chongqing
Tengxin Biological Technology Co., Ltd, China. They were initially housed in pairs in
transparent cages (47 cm L × 32 cm W × 21 cm H) with corn-cob granule for bedding in a
colony on a 12-hour light/dark cycle (lights on at 08:00). Room temperature was maintained
at 22±2°C with a relative humidity of 45–75%. The rats had free access to food and water in
their home cages. One week after arrival, each female rat was placed into the cage of a
proven stud male for 10 days to ensure pregnancy. Following the mating procedure, the
pregnant females were singly housed until parturition after which they were housed together
with their litters for the remainder of the experiment. Experiments were conducted during
the light cycle. Starting 2 or 3 days prior to the expected parturition date, the subjects were
monitored in the morning and afternoon for signs of parturition. Once the dam was found to
be with pups in the morning (that day was designated as postpartum day 1, PPD 1) or in the
afternoon (PPD 0), two shredded paper towels were provided as nesting materials. On PPD
2, each litter was culled to 8 pups (4 males and 4 females with the most visible milk bands).
All animal procedures were approved by the animal care and use committee at Southwest
University, China, and were carried out in compliance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
2.2.

Dugs and choices of doses

Author Manuscript

MDL100907 [a selective 5-HT2A receptor antagonist, (R)-(+)-a-(2,3-dimethoxyphenyl)-1[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol] and quinpirole [a putative D2 dopamine
receptor agonist, (−)-Quinpirole hydrochloride] were purchased from Sigma-Aldrich (St.
Louis, MO, USA). TCB-2 [a high-affinity 5-HT2A agonist, 4-Bromo-3,6dimethoxybenzocyclobuten-1-yl]methylamine hydrobromide] was purchased from Tocris
Bioscience (Ellisville, MO, USA). Haloperidol (HAL, 5.0 mg/ml Ampoules) was purchased
from Hunan Dongting Pharmaceutical Co., Ltd., Hunan, China. TCB-2, haloperidol and
quinpirole were dissolved in 0.9% saline. MDL100907 (1.0 mg/kg, sc) was dissolved in
0.9% saline containing up to 1% glacial acetic acid (Wadenberg et al., 2001a). All drugs
were administered subcutaneously (sc). The chosen dose of MDL100907 was based on our
previous work showing it has no effect on maternal behavior at 1.0 mg/kg (Chen et al.,
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2014). TCB-2 has a disruptive effect on maternal behavior and pup preference at 2.5 mg/kg
(Gao et al., 2018b; Wu et al., 2018). Haloperidol at 0.1 and quinpirole at 1.0 mg/kg disrupt
maternal behavior as observed in the home cage or on an elevated plus maze (Li et al., 2004;
Yang et al., 2015; Zhao and Li, 2009b, 2010). Whether they would also affect pup
preference have not been studied.
2.3. Experiment 1: comparison between mother rats and virgin females in the pup
preference test

Author Manuscript

In our previous studies, we assumed that the pup preference test measures the rewarding
effect of pups, as mother rats spend more time in close proximity to the pups over other
stimuli (Li et al., 2018; Wu et al., 2018). However, we have not validated it. Thus, this first
experiment was designed to determine the validity of this pup preference paradigm by
comparing mother rats with virgin females tested with pups or without pups in an arena.
Specifically, 18 postpartum rats and 16 nulliparous rats were assigned to one of the
following four groups: mother tested with pups (n = 10) or without pups (n = 8), and virgin
females tested with pups (n = 8) or without pups (n = 8).
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Pup preference was tested for five consecutive days from PPD 4–8. One day before the 1st
test (PPD 3), the subject rats were habituated to the testing room and arena for 30 min. They
were brought into the testing room, removed from their home cages and placed into an openfield arena made of black acrylic (50 cm L × 50 cm W × 50 cm H). Inside the arena, there
was a cylinder-shape cage made of transparent acrylic (top and bottom) with stainless metal
bars spaced in between (8.0 cm H × 7.5 cm in diameter). This cage was used to confine 4
pups in the subsequent pup preference tests. On PPD 4–8, the subject rats were brought into
the testing room. 30 min later, they were placed into the arena and their exploration time
with one of two stimuli were recorded for 10 min. One stimulus was 4 pups confined into
the small cage and another one was a cube (6.0 cm L × 6.0 cm W × 6.0 cm H) used as a
novel object. The pup containing cage and object were placed at the center of two adjacent
quadrants at the backend of the arena, while the subject rats were placed midway at the
frontend. They could see, hear and smell the pups but not contact them physically. The total
time spent exploring the two stimuli (in seconds), and the total distance travelled (in
centimeters) during the 10-min period were recorded using a digital video camera and
analyzed using the software of Noldus EthoVision XT 8.5 (Wageningen, The Netherlands).
Exploration was defined as sniffing or touching the cage/object with the nose and/or
forepaws. The arena and the cages were cleaned and deodorized with a 75% ethanol solution
between subjects and after each test. Pup preference is calculated as the ratio of time spent
exploring the pup cage over the total amount of time spent exploring the cage and object.
When tested without pups, the subject rats were only exposed to the cage and cube, no pups
were placed inside the cage.
2.4. Experiment 2: effect of activation or blockade of D2 receptor on pup preference and
maternal responses and its modulation by 5-HT2A receptors
This experiment examined how acute and repeated treatment of quinpirole or haloperidol
alters pup preference and maternal behavior in the home cage, and how activation or
blockade of 5-HT2A receptors by TCB-2 or MDL100907 might change the maternal effects
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of quinpirole or haloperidol. We investigated the repeated drug effects despite the finding
from Experiment 1 showing that mother rats did not differ from virgins on pup preference on
PPD 5–8. The rationale was that the drug effects often undergo a sensitization (increase) or
tolerance (decrease) process with repeated injection and testing (Li, 2016; Stewart and
Badiani, 1993), thus we could potentially observe changes in drug effects from PPD 5 to
PPD 8. Ninety-six postpartum rats were randomly assigned to 1 of the 11 groups. The first 7
groups examined the individual drug effect: VEH+VEH (n = 17), VEH+QUIN 0.5 (n = 8),
VEH+QUIN 1.0 (n = 8), VEH+HAL 0.05 (n = 8), VEH+HAL 0.1 (n = 7), TCB-2 2.5+VEH
(n = 9), MDL100907 1.0+VEH (n = 8). The interactive effects were examined by comparing
the combined drug groups (the TCB-2 2.5+QUIN 1.0, n = 8, TCB-2 2.5+HAL 0.1, n = 9,
MDL100907 1.0+QUIN 1.0, n = 7, or MDL100907 1.0+HAL 0.1, n = 7) with the individual
drug and control groups (The VEH+VEH, VEH+QUIN 1.0, and VEH+HAL 0.1). On each
test day, the mother rats received the first injection of either VEH, TCB-2, or MDL100907
30 min before receiving the second VEH, QUIN or HAL injection. One hour after the
second injection, they were placed into the open-field arena and tested for pup preference on
PPD 4–8.

Author Manuscript
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On PPD 9, maternal behavior was tested in the home cages under the same drug treatment
conditions. The basic procedure was identical to what has been described in our previous
studies (Chen et al., 2014; Zhao and Li, 2009c). Pups were first removed from the dam and
the nest was destroyed. Ten seconds later, the pups were placed back in the cage at the
corner diagonal to the original nest site or the dam sleeping corner. Each test was recorded
by a video camera for 10 min and analyzed manually using a computer with an eventrecording program JWatcher (http://www.jwatcher.ucla.edu). The raters were blind to each
dam’s treatment condition. The following behaviors were recorded and analyzed: pup
retrieval (a rat picking up a pup in her mouth and carrying it back to the nest site), crouching
(a rat positioning herself over the pups with legs splayed to accommodate the pups,
including hover, high and low crouching-over posture), pup licking (a rat placing its tongue
on the anogenital area and the rest of a pup’s body), nest building (a rat picking up nest
material in her mouth and transporting it back to the nest site or pushing the material with
her forepaws towards the nest site). The first pup retrieval latency was defined as the time
elapsed from the first pup approach to the retrieval of the first pup into the nest, and 600s
was assigned to non-responders who did not approach or retrieve the testing pups. After the
test, unretrieved pups were returned to the nest site.
2.5.

Statistical analysis

Author Manuscript

Statistical analyses were performed using SPSS 22 software (SPSS Inc., Chicago, IL, USA).
Pup preference data on each test day (i.e. exploration time and preference ratio) were
analyzed using a factorial repeated measures analysis of variance (ANOVA), with
postpartum state (mother versus virgin females) and test condition (with or without pups)
(Experiment 1), or treatment (Experiment 2) as the between-subjects factors, and object
(pups vs. object) as the within-subjects factor. Data from each test day were analyzed
separately by 2 (VEH vs. quinpirole or haloperidol) × 3 (pretreatment: VEH vs. TCB-2, and
MDL100907) two-way ANOVA. Group differences of pup preference data at each test day
and each stimulus were further investigated using one-way ANOVAs or independent t tests.
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Specific group difference was detected using the LSD post hoc test following the
identification of significant treatment effect or treatment by object interaction. The same
method was used to analyze the home-cage maternal behavior data. In Experiment 2, the
data of maternal behavior in home cage from one rat was missed because of video recording
malfunction. All data are presented as mean ± SEM. Differences were considered
statistically significant if p < 0.05.

3.
3.1.

Results
Experiment 1: comparison between mother rats and virgin females in pup preference

Author Manuscript
Author Manuscript

Both mother rats and virgin females spent more time exploring the cage containing pups
than the object over the five test days, especially when they were tested with pups. Mothers
tended to spend more time than virgin females on exploring the pup cage, but this enhanced
exploration time was observed only on the 1st test day on PPD 4 (Fig. 1). On PPD 4,
repeated measures ANOVA found a main effect of test condition (with or without pups)
(F(1,30) = 18.800, p < 0.001), a main effect of object (pups vs. object) (F(1,30) = 141.793, p
< 0.001). In addition, the maternal state × object, object × test condition (with or without
pups), and object × maternal state × test condition were all significant (all p < 0.024),
suggesting that mother rats differed from the virgins on the pup and object exploration time
and this difference depended on the specific test condition (with or without pups).
Specifically, when tested with pups on PPD 4 (Fig. 1A and B), mother rats spent more time
exploring pups than virgins (t(16) = 3.286, p = 0.005), but their object exploration time was
not significantly different from that of virgins (t(16) = 1.870, p = 0.08). When tested without
pups (Fig. 1A), mother rats spent similar amount of time exploring the cage as virgins did
(t(14) = −0.565, p = 0.581), but spent less time exploring the object (t(14) = −2.806, p =
0.014). With repeated testing on PND 5–8, mother rats did not differ from virgins on the
exploration time with either pups or object (all p > 0.05). The only significant effect was the
object (all p < 0.003), as both groups appeared to explore the pup cage more than the object,
suggesting that the cage itself has a slightly higher intrinsic value than the object.

Author Manuscript

The enhanced pup preference found in mother rats under the pup presence condition was
also apparent in the pup preference ratio. On PPD 4, mother rats tested with pups had a
significantly higher pup preference ratio than mothers tested without pups (t(16) = −5.554, p
<0.001), and virgins tested with pups (t(16) = −2.953, p = 0.009) (Fig. 1C). Mother rats
tested with pups appeared to be more active than those tested without pups (t(16) = −3.071,
p = 0.007), who were also less active than the virgin females (t(14) = −3.155, p = 0.007)
(Fig. 1d). Overall results suggest that the pup preference test is capable of detecting the
emotional responses of mother rats towards pups and discriminating them from virgin
females. With the current setup and chosen stimuli, only the first day appears to be valid in
measuring the specific “maternal” responses. This work lays the foundation for the
subsequent pharmacological work.
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3.2. Experiment 2: effect of activation or blockade of D2 receptor on pup preference and
maternal responses and its modulation by 5-HT2A receptors

Author Manuscript

3.2.1. Individual drug effects on pup preference: Contrasts between
quinpirole and haloperidol, and between TCB-2 and MDL100907—Fig. 2 shows
the exploration time with the pup cage and object and pup preference ratio in mother rats
treated with TCB-2 (2.5 mg/kg), MDL100907 (1.0 mg/kg), quinpirole (0.5 or 1.0 mg/kg),
haloperidol (0.05 or 0.10 mg/kg) on PPD 4. TCB-2 and quinpirole decreased the pup
exploration time and lowered pup preference ratio. Haloperidol increased the pup
exploration time, but did not affect pup preference ratio. MDL100907 had no effect on either
measure. Repeated measures ANOVA on the exploration time showed a main effect of
object (a within-subjects factor; F(1, 58) = 217.425, p < 0.001), treatment (a betweensubjects factor; F(6, 58) = 10.537, p < 0.001), and object × treatment interaction (F(6, 58) =
15.625, p < 0.001). One-way ANOVAs examining the specific group differences showed that
TCB-2 and quinpirole decreased, while haloperidol (0.05 mg/kg) increased the pup
exploration time (all p < 0.005). MDL100907 or haloperidol at 0.1 mg/kg had no effect on
the pup exploration time (all p > 0.411). Only quinpirole at 1.0 mg/kg increased the object
exploration time (p < 0.001). This resulted in a significant decrease in pup preference ratio
in rats treated with TCB-2 and quinpirole (all p < 0.005, Fig. 2C). Furthermore, quinpirole
and haloperidol at 0.1 mg/kg, but not TCB-2 and MDL100907, also significantly suppressed
the movement, as measured by the distance travelled in the arena relative to the vehicle (Fig.
2D), suggesting that the differential effects among these four drugs on pup exploration time
and pup preference are dissociated from their psychomotor effects.

Author Manuscript

3.2.2. Individual drug effects on home-cage maternal behavior—Fig. 3 shows
the home-cage maternal behavior of the mother rats treated with TCB-2 (2.5 mg/kg),
MDL100907 (1.0 mg/kg), quinpirole (0.5 or 1.0 mg/kg), haloperidol (0.05 or 0.10 mg/kg) as
tested on PPD 9. In agreement with our previous reports (Chen et al., 2014; Gao et al.,
2018b; Li, 2015; Li et al., 2004; Zhao and Li, 2012), one single injection (after 5 injections
during pup preference test) of TCB-2, quinpirole and haloperidol on the test day disrupted
various components of maternal behavior, whereas MDL100907 had no effect. One-way
ANOVA revealed a main effect of treatment in the number of pup retrieved (F(6, 58) =
15.175, p < 0.001), but not in the duration of pup crouching (F(6, 58) = 1.778, p = 0.12) and
licking (F(6, 58) = 1.6, p = 0.164), nor nest building (F(6, 58) = 1.108, p = 0.432). Post hoc
LSD tests indicated that rats treated with TCB-2, quinpirole, or haloperidol (0.1 mg/kg, not
at 0.05 mg/kg) retrieved significantly fewer pups (all p < 0.001) than the VEH group.
MDL100907 had no effect on the number of pups retrieved (p = 0.683) (Fig. 3A).
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Taken together, results from the pup preference and home-cage maternal tests reveal
individual drug profiles in maternal behavior: TCB-2 and quinpirole produced a consistent
disruption of both pup preference and home cage maternal behavior. Haloperidol disrupted
maternal behavior in the home cage, but did not disrupt pup preference. MDL100907 had no
effect on either pup preference or maternal behavior in the home cage.
3.2.3. TCB-2 and MDL100907 pretreatment did not alter quinpirole’s
disruption of pup preference, but reduced its enhancement effect of object
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exploration—To examine how activation and blockade of 5-HT2A receptors by TCB-2 and
MDL100907, respectively, modulates the effects of quinpirole, we conducted a 2 [VEH vs.
QUIN] × 3 [VEH, TCB-2, and MDL100907] ANOVA on the pup preference PPD 4 data
from mother rats pretreated with VEH (the VEH+VEH and VEH+QUIN groups) and those
pretreated with either TCB-2 (the TCB-2+VEH and TCB-2+QUIN groups) or MDL100907
(the MDL100907+VEH and MDL100907+QUIN groups).

Author Manuscript

On the pup exploration time (Fig. 4A), pretreatment of TCB-2 but not MDL100907 had a
stronger suppression in rats treated with VEH than those with quinpirole. Two-way ANOVA
showed a main effect of pretreatment (F(2, 51) = 19.234, p < 0.001), quinpirole (F(1, 51) =
12.386, p = 0.001), and the interaction between the two (F(2, 51) = 3.918, p = 0.026). This
interactive effect reflects the significantly suppressive effect of TCB-2 (not MDL100907) on
the VEH-treated rats (VEH+VEH vs. TCB-2+VEH) and the lack of the effect on the
quinpirole-treated ones (TCB-2+VEH vs. TCB-2+QUIN). Post hoc LSD tests confirmed
that TCB-2 (p < 0.001) but not MDL100907 (p = 0.412) decreased the pup exploration time.
One-way ANOVA followed by post hoc LSD tests further showed that the rats treated with
either quinpirole, TCB-2 or their combination (i.e., the VEH+QUIN 1.0, TCB-2 2.5+VEH,
TCB-2 2.5+QUIN 1.0 and MDL100907+QUIN 1.0) all had a significantly lower pup
exploration time than the VEH+VEH group (all p < 0.003), reflecting the treatment effect of
quinpirole and TCB-2. Pretreatment of TCB-2 or MDL100907 before quinpirole did not
alter quinpirole’s disruption of pup exploration (due to the floor effect).

Author Manuscript

Fig. 4B shows that the object exploration time was increased by quinpirole, however,
pretreatment of TCB-2 or MDL100907 before quinpirole reduced the quinpirole’s
increasing effect on object exploration. Two-way ANOVA showed a significant interaction
between pretreatment and quinpirole (F(2, 51) = 4.251, p = 0.02), but no main effect of
pretreatment (F(2, 51) = 1.499, p = 0.233), or quinpirole (F(1, 51) = 2.627, p = 0.111). Oneway ANOVA followed by post hoc LSD tests showed that only the VEH+QUIN 1.0 group
had an increased object exploration time than the VEH+VEH group (p = 0.001). However,
this treatment effect disappeared when TCB-2 or MDL100907 was added in the treatment
(no significant group difference between the TCB-2 2.5+QUIN 1.0 or MDL100907
1.0+QUIN 1.0 and VEH+VEH group, p = 0.437 or 0.582, respectively). There was also a
significant group difference between the TCB-2 2.5+QUIN 1.0 or MDL100907 1.0+QUIN
1.0 and the VEH+QUIN 1.0 group (p = 0.025 or 0.02, respectively), indicating the
significant reduction by TCB-2 and MDL100907 on quinpirole’s enhancing effect on object
exploration. All these results suggest that TCB-2 or MDL100907 attenuated the quinpirole’s
increasing effect on object exploration.

Author Manuscript

Like its effect on the pup exploration time, TCB-2 or MDL100907 did not alter quinpirole’s
effect of pup preference ratio, but reduced the VEH-treated dams (Fig. 4C). Twoway
ANOVA showed a main effect of pretreatment (F(2, 51) = 21.629, p < 0.001), but no main
effect of quinpirole (F(1, 51) = 2. 852, p = 0.097), or the interaction between the two (F(2,
51) = 3.008, p = 0.058). Post hoc LSD tests revealed that TCB-2, but not MDL100907
decreased the pup preference ratio (p < 0.001).
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On the distance travelled (a measure of motor activity, Fig. 4D), two-way ANOVA showed a
main effect of pretreatment (F(2, 51) = 5.561, p = 0.007), but no main effect of quinpirole
(F(1, 51) = 0, p = 0.995), nor the interaction between them (F(2, 51) = 2.361, p = 0.105).
Post hoc LSD tests revealed that TCB-2 (p = 0.016) but not MDL100907 (p = 0.475)
increased the distance travelled in the arena.
Taken together, results from this analysis reveals that TCB-2 and MDL00907 did not alter
quinpirole’s suppressive effect on pup preference, mainly due to the floor effect. However,
TCB-2 and MDL00907 individually did reduce quinpirole’s increasing effect on object
exploration. Thus, MDL100907 shares a similar effect with TCB-2 in reducing quinpirole’s
effect on object exploration.

Author Manuscript
Author Manuscript

3.2.4. Neither TCB-2 nor MDL100907 pretreatment altered the quinpirole’s
disruption of home-cage maternal behavior—Next, we examined the possible
pretreatment effects of TCB-2 and MDL100907 on quinpirole-induced disruption of homecage maternal behavior. Quinpirole and TCB-2, but not MDL100907 decreased various
components of home-cage maternal behavior. Two-way ANOVA on the number of pups
retrieved showed a main effect of pretreatment (F(2, 51) = 17.014, p < 0.001), quinpirole
(F(1, 51) = 36.658, p < 0.001), and a significant interaction between the two (F(2, 51) =
6.82, p = 0.002). Post hoc LSD tests revealed that TCB-2 (p < 0.001) but not MDL100907 (p
= 0.628) decreased the number of pups retrieved. In addition, quinpirole-treated mother rats
also spent less time crouching over pups (F(1, 51) = 6.424, p = 0.014), licking pups (F(1, 51)
= 4.352, p = 0.042), but not building nest (F(1, 51) = 1.317, p = 0.257). None of these effects
of quinpirole was altered by 5-HT2A pretreatment (TCB-2 or MDL100907), as its
interaction with quinpirole was not significant (all p > 0.248). Therefore, neither TCB-2 nor
MDL100907 altered the quinpirole’s disruption of home-cage maternal behavior.

Author Manuscript

3.2.5. Neither TCB-2 nor MDL100907 pretreatment altered the haloperidol’s
lack effect on pup preference. However, haloperidol attenuated TCB-2’s
disruptive effect on pup preference—To examine how activation or blockade of 5HT2A receptors by TCB-2 or MDL100907, respectively modulates the haloperidol’s effect
on pup preference, the data from mother rats treated with VEH or haloperidol (0.1 mg/kg)
on the 1st test day (PPD 4) were analyzed together with those from the dams pretreated with
VEH, TCB-2 or MDL100907 (e.g., haloperidol together with VEH, TCB-2 at 2.5 mg/kg or
MDL100907 at 1.0 mg/kg). As haloperidol by itself did not alter pup preference, while
TCB-2 disrupted it, we also examined how haloperidol might alter TCB-2’s effect. Fig. 5
shows the exploration time with the pup cage and object, pup preference ratio, and total
distance moved in the six groups.
On the pup exploration time (Fig. 5A), two-way ANOVA showed a main effect of
pretreatment (F(2, 51) = 32.628, p < 0.001), but no main effect of haloperidol (F(1, 51) =
1.58, p = 0.215), nor their interaction (F(2, 51) = 0.238, p = 0.789). Post hoc LSD tests
revealed that TCB-2 (p < 0.001) but not MDL100907 (p = 0.992) decreased the pup
exploration time.
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TCB-2 decreased the object exploration time, especially in the haloperidol-treated dams.
Two-way ANOVA showed a significant interaction between the 5-HT2A pretreatment and
haloperidol (F(2, 51) = 6.392, p = 0.003). One-way ANOVA followed by the post hoc tests
showed that the TCB-2 2.5+HAL 0.1 group spent significantly less time on object
exploration than the VEH+VEH group (p = 0.039), the VEH+HAL 0.1 and TCB-2
2.5+VEH groups (p = 0.026, 0.003, respectively). In contrast, the MDL100907 1.0+HAL 0.1
group spent significantly more time than the VEH+VEH group (p = 0.046) (Fig. 5B). More
importantly, despite its lack of effect on pup preference, haloperidol reduced TCB-2-induced
disruption of the pup preference ratio (Fig. 5C). Two-way ANOVA revealed a main effect of
5-HT2A pretreatment (F(2, 49) = 8.679, p = 0.001), haloperidol (F(1, 49) = 4.453, p = 0.04),
and the interaction between the two (F(2, 49) = 5.44, p = 0.007). Post hoc tests revealed that
TCB-2 (p < 0.001) but not MDL100907 (p = 0.554) decreased the pup preference ratio of
the VEH-treated group, as the TCB-2 2.5+VEH group had a significantly lower pup
preference ratio than the VEH+VEH group (p < 0.001), but the TCB-2 2.5+HAL 0.1 group
did not differ from the VEH+VEH group (p = 0.407). TCB-2 2.5+HAL 0.1 group actually
had a higher pup preference ratio than the TCB-2 2.5+VEH group (p < 0.001), reflecting
that haloperidol attenuated the TCB-2’s disruptive effect on pup preference.
On the distance travelled (Fig. 5D), two-way ANOVA showed only a main effect of
haloperidol (F(1, 51) = 17.156, p < 0.001), but no main effect of 5-HT2A pretreatment (F(2,
51) = 1.346, p = 0.269), or the interaction between the two (F(2, 51) = 1.088, p = 0.345), a
finding consistent with the motor suppressive profile of haloperidol.

Author Manuscript
Author Manuscript

3.2.6. TCB-2, but not MDL100907 pretreatment enhanced haloperidol’s
disruption of pup retrieval in the home cage—Fig. 6 shows the home-cage maternal
behavior data from the mother rats treated with haloperidol (0.1 mg/kg), and haloperidol (0.1
mg/kg) together with TCB-2 (2.5 mg/kg) or MDL100907 (1.0 mg/kg). Both TCB-2 and
haloperidol decreased the number of pups retrieved, and TCB-2 enhanced haloperidol’s
disruption effect. Two-way ANOVA showed a main effect of 5-HT2A pretreatment (F(2, 50)
= 19.353, p < 0.001), haloperidol (F(1, 50) = 42.573, p < 0.001), and the interaction between
the two (F(2, 50) = 6.87, p = 0.002). Post hoc LSD tests revealed that TCB-2 (p < 0.001) and
MDL100907 (p = 0.005) decreased the number of pups retrieved in the haloperidoltreatment groups. One-way ANOVA followed by post hoc LSD tests showed that the VEH
+HAL 0.1, TCB-2 2.5+VEH, TCB-2 2.5+HAL 0.1, and MDL100907+HAL 0.1 groups all
retrieved significantly fewer pups than the VEH+VEH group (all p < 0.001). Importantly, the
TCB-2 2.5+HAL 0.1 group (p = 0.027) but not MDL100907+HAL 0.1 group (p = 0.056)
retrieved even fewer pups than the VEH+HAL 0.1 group. On other maternal responses, the
main effects of 5-HT2A pretreatment and haloperidol, and their interaction all failed to reach
a significant level (all p > 0.067), except that haloperidol significantly decreased the nest
building duration (F(1, 50) = 7.815, p = 0.007).
Over all, these data indicate that TCB-2 enhanced haloperidol’s disruption of pup retrieval in
the home cage, and MDL100907 is ineffective to alter haloperidol’s effect on maternal
behavior. Haloperidol also reduced the pup preference disruption induced by TCB-2.
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The 5-HT2A and D2 receptors have a functional crosstalk (Albizu et al., 2011) and they are
all richly expressed in the mesolimbic and mesocortical systems (Azmitia and Segal, 1978;
McMahon et al., 2001), providing the neuroanatomical basis for their interaction. The
present study examined to what extent acute and repeated activation or blockade of 5-HT2A
receptors modulates dopamine D2-mediated effects on pup preference and home-cage
maternal behavior. After we validated the pup preference paradigm, we found that acute
administration of TCB-2 and quinpirole suppressed pup preference mainly by decreasing the
pup exploration time. In contrast, acute haloperidol injection had no effect (1.0 mg/kg) or
even an opposite effect (0.05 mg/kg) on pup exploration. At 0.05 mg/kg, haloperidol
selectively increased the pup exploration time without affecting the object exploration.
MDL100907 had no effect on the pup and object exploration time and pup preference ratio.
In the subsequent home-cage maternal behavior test, TCB-2, quinpirole and haloperidol all
caused a similar disruption of active maternal responses, especially the pup retrieval. Once
again, MDL100907 failed to alter any maternal response in the home cage. When used
together, TCB-2 was found to enhance haloperidol’s disruption of home-cage pup retrieval,
but did not alter quinpirole’s pup preference and home-cage maternal disruption (due to the
floor effect). MDL100907 did not change quinpirole’s disruption of pup preference and
home-cage maternal behavior, nor haloperidol’s maternal effects. These findings suggest
that activation of 5-HT2A receptors (TCB-2) is capable of enhancing D2-mediated disruption
of maternal performance, whereas blockade of 5-HT2A receptors (MDL100907) is less
effective to alter D2 mediated maternal effects. They also indicate that 5-HT2A receptors
may have a direct effect on maternal behavior independent of their interaction with D2
receptors.
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Naïve virgin female rats generally avoid infant rats, while mother rats are attracted to them
and show a strong pup preference over other stimuli. Through maternal experience, mother
rats develop strong social and emotional attachment towards the pups, as evidenced by the
findings that they often increase their licking and nursing towards pups after a brief
separation from their litters and exhibit depression-like behaviors if they experience a long
period of repeated separation from their pups (Boccia et al., 2007). In the laboratory, the
rewarding and reinforcing effect of pups has been investigated using the conditioned place
preference (CPP) paradigm in which mother rats show a clear preference to a pup-associated
environment over a neutral one after allowing several days of pup-mother interactions in the
conditioning box (Fleming et al., 1994). In the present study, we used the pup preference test
to assess this mother-infant bond (Olazabal et al., 2013). This test differs from the pup CPP,
as it is a direct measure of emotional attachment towards pups, the so called “liking” aspect
of maternal behavior (Berridge and Robinson, 2003) because it does not require any
conditioning and any effort put forth by the mothers. We found that mother rats differed
from virgins in their attractiveness to pups. Mothers tended to spend more time than virgin
females on exploring the pup cage when they were tested with pups. When tested without
pups, mother rats had similar amount of time exploring the cage as the virgins did. One
drawback with the current setup is that the mother-virgin difference only appeared on the 1st
test day and did not persist throughout the five-day testing period. This may be due to the
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unexpected higher intrinsic rewarding value of the cage (i.e., ~60% preference ratio even for
the empty cage). In the future work, we will use two identical copies of the cage to see if the
mother-virgin difference will persist throughout the postpartum period.

Author Manuscript

Mother rats acutely treated with quinpirole (0.5 and 1.0 mg/kg) decreased the pup
exploration time but increased the object exploration, so they showed a significantly lower
pup preference ratio. They also showed impaired maternal performance in the home cage,
consistent with our previous study (Zhao and Li, 2010). Behaviorally, it is possible that
quinpirole may have decreased the emotional processing of the rewarding value of pups and
this suppression could explain quinpirole’s effects in both tests. In a food-induced
conditioned place preference test, Liu et al. (2008) reported that microinjections of
quinpirole into the posteromedial VTA led to conditioned place aversion. Quinpirole
administered to this site also decreased food intake and basal dopamine concentration in the
ventromedial striatum. Based on the finding that quinpirole microinjected into the
posteromedial VTA reduces dopamine cell firing (Beckstead et al., 2004; Olijslagers et al.,
2004), they concluded that inhibition of midbrain dopamine neurons causes a negative
affective state and disrupts positive affective encoding of food reward. The same could be
said regarding pup reward. Quinpirole may have made mother rats aversive to pups, leading
them to reduce their pup exploration time. This idea could be tested in a pup place
preference test to see if quinpirole causes mother rats to develop a conditioned place
aversion to the pup associated environment.

Author Manuscript

Besides this possibility, quinpirole could also disrupt maternal behavior by impairing certain
aspects of executive function, such as behavioral organization, attention and working
memory, etc. Other studies have shown that D2 activation often causes perseverative
responding, deficit in attention and working memory (Agnoli et al., 2013; Bushnell and
Levin, 1993; Herold, 2010; Liu et al., 2008; Pezze et al., 2007; Wang et al., 2004). Under the
influence of quinpirole, a mother rat might lose its ability to select and maintain appropriate
behavioral responses in the presence of pups. Collectively, quinpirole may disrupt maternal
behavior through at least two possible behavioral mechanisms targeting two different brain
areas. Quinpirole may cause a negative affect towards pups by acting on the D2
autoreceptors in the VTA (Liu et al., 2008), while it may disrupt executive functions
necessary for normal maternal behavior by targeting the postsynaptic D2 receptors in the
mPFC (Wang et al., 2004). Indeed, previous work does show that quinpirole significantly
increases c-Fos expression in the mPFC, while it reduces c-Fos expression in the nucleus
accumbens in postpartum female rats (Zhao and Li, 2010). Apparently, this intriguing idea
needs to be rigorously tested in the future.
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Although haloperidol, like quinpirole, disrupted home-cage maternal behavior, it did not
suppress pup preference. Haloperidol is well known for its suppression on maternal
motivation (Giordano et al., 1990; Li et al., 2004; Silva et al., 2001; Stern and Keer, 1999;
Zhao and Li, 2010). This idea is supported by extensive evidence showing that haloperidolinduced maternal disruption can be reduced to some extent by 4-h pup separation (Zhao and
Li, 2009c); and haloperidol selectively suppresses behavioral measures indicative of
maternal motivation (Stern and Keer, 1999; Yang et al., 2015). The dissociation between
haloperidol’s lack of effect on pup preference and its strong disruption of home-cage
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maternal behavior suggests that our pup preference test may not measure the motivational
aspect of reward (pups) processing, especially the behavioral activation and effort-related
aspects of maternal motivation (Salamone et al., 2016), but rather, measures the innate
emotional aspect of reward processing and/or how a mother rat organizes its activities in
response to two competing stimuli. These findings also suggest that a multi-test approach is
often necessary to reveal the neurochemistry of specific psychological functions underlying
maternal behavior. Although we were initially interested in how TCB-2 and MDL100907
alter the maternal effects of haloperidol, we also found that haloperidol reduced TCB-2induced disruption of pup preference, indicating that blocking D2 receptors can also reduce
5-HT2A activation-induced maternal disruption. This action may be explained by
haloperidol’s inverse agonist action against 5-HT2A receptors (Weiner et al., 2001).
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Consistent with our previous study (Gao et al., 2018b; Wu et al., 2018), we found that
TCB-2 disrupted both pup preference and home-cage maternal behavior. Based on the
findings that 4-h pup separation (a technique presumably increases maternal motivation)
failed to attenuate the TCB-2-induced maternal disruption and TCB-2-treated dams showed
an increased pup preference in a pup-male preference test, we suggested that TCB-2 is
unlikely to have a disruptive effect on motivational and emotional processing of the
rewarding property of pups (TCB-2 may actually have an enhancement effect on pup
reward). Rather, we proposed that TCB-2 could disrupt pup preference and maternal
behavior by disrupting the executive function (Wu et al., 2018), giving its well-known
hallucinatory effect and its disruption of impulsive response and behavioral organization
(Koskinen et al., 2000a; Koskinen et al., 2000b; Winstanley et al., 2004). TCB-2 is
speculated to disrupt maternal behavior and pup preference by either diverting a mother rat’s
focused attention on pups towards other environmental cues, and by making her more easily
distracted by irrelevant environmental stimuli, or by increasing behavioral fragmentation and
premature, or ‘impulsive’ responding. This hallucinogenic behavioral effect of TCB-2 in rat
maternal behavior is also supported by the finding that activation of 5-HT2A receptors in the
mPFC is responsible for TCB-2’s maternal effects (Gao et al., 2018b). This effect may be
partially achieved through excessively stimulating dopamine release in the mesocortical and
mesolimbic dopamine systems (Di Giovanni et al., 2000; Di Matteo et al., 2002), which in
turn may cause a disruption of executive function. However, we do not have any direct
evidence showing that activation of 5-HT2A receptors causes disorganized maternal
responses, which should be examined in the future.
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Our hypothesis that both TCB-2 and quinpirole disrupt executive function of dams, whereas
haloperidol mainly disrupts maternal motivation can be applied successfully to explain the
findings that TCB-2 did not alter quinpirole’s disruption of pup preference and home-cage
maternal behavior, but enhanced haloperidol’s disruption of pup retrieval in the home cage.
In the case of quinpirole, because both TCB-2 and quinpirole act on the same psychological
process (i.e., executive function), the lack of modulation by TCB-2 on quinpirole-induced
home-cage maternal disruption may reflect the floor effect of both drugs on executive
function. In the case of haloperidol, because TCB-2 and haloperidol disrupt executive
function and maternal motivation separately, the enhancement effect of TCB-2 on
haloperidol-induced disruption of home-cage maternal behavior may reflect the additive
effect of TCB-2’s disruption of executive function on top of haloperidol’s disruption of
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maternal motivation. Apparently, this hypothesis needs to be further tested before we can
accept its validity.
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MDL100907 at 1.0 mg/kg by itself did not alter pup preference or home-cage maternal
behavior, a finding consistent with our previous report (Chen et al., 2014; Nie et al., 2018). It
also did not change quinpirole’s and haloperidol’s effects in these two tests. Our finding on
the MDL100907 and quinpirole interaction is consistent with a previous report showing that
MDL100907 is ineffective in reducing contralateral rotational behavior induced quinpirole
in adult rats with unilateral DA lesions (Taylor et al., 2006). The literature on the
MDL100907 and haloperidol interaction is mixed, and three possible outcomes have been
reported: a potentiation (Wadenberg et al., 2001b); a reduction (Benaliouad et al., 2007); and
no effect (Creed-Carson et al., 2011; Gao et al., 2018a; Reavill et al., 1999). These findings,
together with the present ones, suggest that the interactions between 5-HT2A and D2
receptors are much more complex than we originally thought, and may depend on specific
D2-mediated behaviors. Indeed, we recently used a pup retrieval on an elevated plus maze
test (a test of maternal anxiety, maternal motivation, executive function and their
interactions) and found that MDL100907 exacerbated the quinpirole-induced disruption of
pup retrieval (Nie et al., 2018), supporting the notion that 5-HT2A blockade’s modulation on
D2-mediated maternal effects also depends on the specific behavioral tests, which rely on
different psychological processes with different degrees of sensitivity to the D2 × 5-HT2A
interactions.
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In conclusion, the present study further demonstrates that the balanced dopamine D2mediated neurotransmission is critically important for the normal expression of maternal
behavior. Stimulation or blockade this receptor by quinpirole and haloperidol, respectively,
induces a change in pup preference and home-cage maternal behavior likely through
different behavioral mechanisms. Quinpirole may disrupt maternal behavior by causing a
negative maternal affect or disrupting executive function; whereas haloperidol may do so by
suppressing maternal motivation. Importantly, we found an important modulation of 5-HT2A
on D2-mediated maternal effects: activation of 5-HT2A receptors by TCB-2 enhances D2mediated suppression of maternal motivation, whereas blockade of 5-HT2A receptors by
MDL100907 is less effective to alter D2-mediated maternal effects. Future work will
examine the neural basis of the interactive actions between D2 and 5-HT2A receptors and
further elucidate the relevant behavioral mechanisms.
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Highlights
1.

Activation of D2 (Quinpirole) or 5-HT2A (TCB-2) receptors suppressed pup
preference

2.

TCB-2, quinpirole, or haloperidol disrupted home-cage maternal behavior

3.

TCB-2, but not MDL100907, enhanced haloperidol’s disruption of pup
retrieval

4.

Haloperidol reduced TCB-2’s disruptive effect on pup preference

5.

TCB-2 or MDL100907 did not affect quinpirole’s disruption of pup
preference
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Fig. 1.

Comparison between mother rats and virgin females in the pup preference test on PPD 4.
Duration of pup exploration time (A), object exploration time (B), pup preference ratio (C),
and distance travelled (D) on PPD 4 are presented as mean ± SEM. *p < 0.05, **p < 0.01
significant difference between mother and virgin females; ##p < 0.01, +++p < 0.001
significant difference between two different test conditions (pup presence vs. pup absence).
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Effects of individual drugs that stimulate or block D2 or 5-HT2A receptors on pup
preference. Duration of pup exploration time (A), object exploration time (B), pup
preference ratio (C), and distance travelled (D) in mother rats treated with TCB-2 (2.5 mg/
kg), MDL100907 (1.0 mg/kg), quinpirole (QUIN, 0.5 or 1.0 mg/kg), or haloperidol (HAL,
0.05 or 0.10 mg/kg) on PPD 4 are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p <
0.001 significant difference from VEH+VEH group.
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Fig. 3.

Effects of individual drugs that stimulate or block D2 or 5-HT2A receptors on home-cage
maternal behavior on PPD 9. Number of pups retrieved (A), duration of pup crouching (B),
duration of pup licking (C), and duration of nest building (D) in mother rats treated with
TCB-2 (2.5 mg/kg), MDL100907 (1.0 mg/kg), quinpirole (QUIN, 0.5 or 1.0 mg/kg), or
haloperidol (HAL, 0.05 or 0.10 mg/kg) and tested in the home cage are presented as mean ±
SEM. ***p < 0.001 significant difference from VEH+VEH group.
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Fig. 4.

Modulation of activation or blockade of 5-HT2A receptors on quinpirole’s effect on pup
preference. Duration of pup exploration time (A), object exploration time (B), pup
preference ratio (C), and distance travelled (D) in mother rats treated with quinpirole (QUIN,
1.0 mg/kg), or quinpirole together with TCB-2 (2.5 mg/kg) or MDL100907 (1.0 mg/kg) are
expressed as mean ± SEM. **p < 0.01, ***p < 0.001 significant difference from VEH+VEH
group; #p < 0.05, ##p < 0.01 significant difference from VEH+QUIN 1.0 group; +++p <
0.001 significant difference between TCB-2 and VEH treatment.
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Fig. 5.

Modulation of activation or blockade of 5-HT2A receptor on haloperidol’s effect on pup
preference. Duration of pup exploration time (A), object exploration time (B), pup
preference ratio (C), and distance travelled (D) in mother rats treated with haloperidol
(HAL, 0.1 mg/kg), or haloperidol together with TCB-2 (2.5 mg/kg) or MDL100907 (1.0
mg/kg) are expressed as mean ± SEM. *p < 0.05, ***p < 0.001 significant difference from
VEH+VEH group; #p < 0.05 significant difference from VEH+HAL 0.1 group; $ $p < 0.01,
$ $ $p < 0.001 significant difference from TCB-2 2.5+VEH group; +++p < 0.001 significant
difference between TCB-2 and VEH treatment.
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Fig. 6.

Modulation of activation or blockade of 5-HT2A receptor on haloperidol’s effect on homecage maternal behavior. Number of pups retrieved (A), latency of first pup retrieval (B),
latency of last pup retrieval (C), duration of pup crouching (D), duration of pup licking (E),
and duration of nest building (F) in mother rats treated with haloperidol (0.1 mg/kg), or
haloperidol together with TCB-2 (2.5 mg/kg) or MDL100907 (1.0 mg/kg) and tested in the
home cage are presented as mean ± SEM. ***p < 0.001 significant difference from VEH
+VEH group; #p < 0.05 significant difference from VEH+HAL 0.1 group; VEH+HAL 0.10
group. ++p < 0.01, +++p < 0.001 significant difference between TCB-2 or MDL100907 and
VEH treatment.
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